Skip to main content

stock

PHIO · Phio Pharmaceuticals Corp.

What Phio Pharmaceuticals Corp. reports to the SEC, read from its filings.

Open in the app

Price

The live PHIO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PHIO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
11,617,250 as of 2026-08-04 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-102.4%
ROA
-90.2%

Health

Current ratio
—
Debt/equity
—

Deep value

NCAV
$12.59M
NCAV per share
$1.08
Price/NCAV
Locked
NNWC
$11.29M
NNWC per share
$0.97
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$4.27M-$4.14M
10-Q filed 2026-08-06
2026-03-31——Gross profit: unreported by this company.-$4.17M-$4.00M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.-$2.53M-$2.37M
DEF 14A filed 2026-08-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——Gross profit: unreported by this company.-$2.50M-$2.39M
10-Q filed 2025-11-13
2025-06-30——Gross profit: unreported by this company.-$2.31M-$2.17M
10-Q filed 2026-08-06
2025-03-31——Gross profit: unreported by this company.-$1.87M-$1.77M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——Gross profit: unreported by this company.-$1.67M-$1.63M
DEF 14A filed 2026-08-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——Gross profit: unreported by this company.-$1.59M-$1.52M
10-Q filed 2025-11-13
Assets
$14.31M
Equity
$12.60M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$9.22M-$8.70M-$7.99M
2024-12-31—-$7.39M-$7.15M-$7.11M
2023-12-31—-$10.82M-$10.83M-$10.75M
2022-12-31—-$11.46M-$11.48M-$12.25M
2021-12-31—-$13.51M-$13.29M-$11.91M
2020-12-31$0-$8.79M-$8.79M-$8.82M
2019-12-31$21,000-$8.99M-$8.91M-$8.72M
2018-12-31$138,000-$7.36M-$7.36M-$7.53M
2017-12-31$15,000-$14.06M-$12.45M-$9.72M
2016-12-31$19,000-$9.02M-$8.99M—

Company filings

since Thu Nov 20 · 2 offering filings in 12 months · since Wed Apr 8

events

  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Sep 288-K
  • Other event

    Other event
    Sep 148-K
  • Results

    Results
    Aug 68-K
  • Executive or director change, Other event

    Executive or director changeOther event
    Jul 218-K
  • Results

    Results
    May 78-K
  • Material agreement

    Material agreement
    Apr 88-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Plott Ronald Todd

    Director

    Buy$10,350

    Sep 30, 4:01 PM ET

  • BRADFORD PATRICIA A

    Director

    Buy$6,583

    Sep 25, 4:01 PM ET

  • Bitterman Robert J

    Chairman, Pres. & CEO, Director

    Buy$2,058

    Sep 23, 4:01 PM ET

  • BRADFORD PATRICIA A

    Director

    Buy$12,360

    Sep 16, 4:01 PM ET

  • Plott Ronald Todd

    Director

    Buy$17,100

    Aug 20, 8:30 AM ET

All insider trades for PHIO

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named PHIO, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about PHIO.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about PHIO.

nakagai

Signals on PHIO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PHIO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Phio Pharmaceuticals Corp. (PHIO): SEC filings, financials and insider trades · Nakagai